CBLL vs EXAS · rev $65.4M vs rev $2.76B
CeriBell, Inc (CBLL) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
CeriBell, Inc (CBLL) is a medical devices company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CBLL revenue for 2024-12-31 was $65.4M. Net income was -$40.5M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. CBLL currently screens at market cap $768.1M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CBLL currently screens at market cap $768.1M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CBLL and EXAS stock pages for the full models.
Not investment advice.